Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer ; volume:135 ; number:1 ; day:29 ; month:7 ; year:2012 ; pages:241-252 ; date:8.2012
Breast cancer research and treatment ; 135, Heft 1 (29.7.2012), 241-252, 8.2012
- Urheber
-
Boer, Richard H. De
Kotasek, Dusan
White, Shane
Koczwara, Bogda
Mainwaring, Paul
Chan, Arlene
Melara, Rebeca
Ye, Yining
Adewoye, Adeboye H.
Sikorski, Robert
Kaufman, Peter A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-012-2135-0
- URN
-
urn:nbn:de:101:1-2019101518585065717094
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boer, Richard H. De
- Kotasek, Dusan
- White, Shane
- Koczwara, Bogda
- Mainwaring, Paul
- Chan, Arlene
- Melara, Rebeca
- Ye, Yining
- Adewoye, Adeboye H.
- Sikorski, Robert
- Kaufman, Peter A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
A multiple comparison procedure for dose‐finding trials with subpopulations
Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
Response-adaptive dose-finding under model uncertainty
Optimal dose‐finding for efficacy–safety models
Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes
Experiences with an adaptive design for a dose-finding study in osteoarthritis
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
A multiple comparison procedure for dose‐finding trials with subpopulations
Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
Response-adaptive dose-finding under model uncertainty
Optimal dose‐finding for efficacy–safety models
Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes
Experiences with an adaptive design for a dose-finding study in osteoarthritis
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties
Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
A multiple comparison procedure for dose‐finding trials with subpopulations
Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
Response-adaptive dose-finding under model uncertainty
Optimal dose‐finding for efficacy–safety models
Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes
Experiences with an adaptive design for a dose-finding study in osteoarthritis
Pharmakokinetik der Taxane : (Paclitaxel und Docetaxel)
Revisiting dose-finding of monoclonal antibodies in migraine
Dose-Finding Designs: The Role of Convergence Properties